Skip to main content

Table 2 Minimum inhibitory concentrations (MIC µg/mL) for clinical isolates of compounds (10), (13), (14), (16), (25) and (30)

From: Synthesis, characterization and evaluation of 1,3,5-triazine aminobenzoic acid derivatives for their antimicrobial activity

Test compound MRSA E. coli
Ampicillin >200 >200
10 25 100
13 100 25
14 >200 100
16 100 >200
25 100 100
30 >200 >200
  1. MRSA methicillin-resistant Staphylococcus aureus